|
Market Closed -
Nasdaq
16:00:00 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 0.2393 USD | +13.63% |
|
+4.86% | -76.07% |
| 09-30 | TScan Therapeutics, Inc. Announces Departure of Chrystal Louis as Chief Medical Officer | CI |
| 09-30 | TScan Therapeutics, Inc. Announces Cessation of Jason A. Amello as Chief Financial Officer | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 16.22M | - | - | - | ||
| 68.98B | |||||
| 53.15B | |||||
| 50.83B | |||||
| 44.61B | |||||
| 40.57B | - | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
